The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair–proficient (MMR-p) advanced colorectal cancer.
 
Mark Yarchoan
Consulting or Advisory Role - Eisai; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Anna K. Ferguson
No Relationships to Disclose
 
Jennifer N. Durham
No Relationships to Disclose
 
Noah Rozich
No Relationships to Disclose
 
Christina Rodriguez
No Relationships to Disclose
 
Chiung-Yu Huang
No Relationships to Disclose
 
Ilene S. Browner
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
 
Dung T. Le
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
 
Dan Laheru
Patents, Royalties, Other Intellectual Property - Colon GVAX
 
Ross C. Donehower
No Relationships to Disclose
 
Elizabeth M. Jaffee
Consulting or Advisory Role - Adaptive Biotechnologies; CStone Pharmaceuticals; Dragonfly Therapeutics; Genocea Biosciences; Incyte
Research Funding - Aduro Biotech; Amgen; Bristol-Myers Squibb; Corvus Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genocea Biosciences; MedImmune
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - AstraZeneca; Biosynergies; Merck; Merrimack; novarock
Research Funding - Amgen; Bristol-Myers Squibb; Gradalis; Halozyme; ITeos Therapeutics; Merck
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
 
Nilofer Saba Azad
Honoraria - AMAG Pharmaceuticals; Bayer/Onyx
Consulting or Advisory Role - AMAG Pharmaceuticals; Dava Oncology
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Intensity Therapeutics; Merck (Inst); Syndax (Inst)